Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Mixture / Pink Cocaine / Tusi
Mixture

Pink Cocaine / Tusi

A pink-dyed street mixture — usually ketamine + MDMA, and rarely 2C-B. See the full pink cocaine guide.

Overview

"Pink cocaine" — also called tusi, tucibi, or tusibi — is not a single substance but a pink-dyed powder mixture sold under a borrowed name. Laboratory analysis of seized samples most often identifies a combination of ketamine and MDMA, sometimes with caffeine or other additives, and only rarely any 2C-B (the compound the name is loosely derived from). The pink dye is cosmetic and says nothing about the contents.

Source: Public reporting from U.S. Drug Enforcement Administration drug fact sheets, dea.gov and U.S. National Institute on Drug Abuse (NIDA), nida.nih.gov on emerging drug mixtures.

Chemistry & mechanism of action

Because it is a variable mixture, tusi has no single mechanism of action; its effects come from whatever drugs a given batch actually contains. Where ketamine is present it acts mainly as an NMDA-receptor antagonist (a dissociative); where MDMA is present it increases release of serotonin and other monoamines. Two samples sold as the same thing can therefore behave very differently.

Source: U.S. National Institute on Drug Abuse (NIDA), nida.nih.gov; PubChem, U.S. National Library of Medicine compound records for ketamine and MDMA.

Effects

Reported effects depend entirely on the mixture and dose, and are inherently unpredictable. A batch weighted toward MDMA tends to feel stimulating; one weighted toward ketamine tends to feel sedating and dissociative. The core hazard is that the user cannot know which they are taking, or how much.

Source: U.S. National Institute on Drug Abuse (NIDA), nida.nih.gov

Risks & harms

The central risk of tusi is the unknown: unknown ingredients and unknown doses make accidental overdose and dangerous drug combinations more likely. Combining a stimulant (MDMA) with a dissociative (ketamine), or either with alcohol, raises the load on the heart and the risk of overheating, dehydration, and loss of consciousness. Samples have also been found adulterated with other substances.

Source: U.S. National Institute on Drug Abuse (NIDA), nida.nih.gov; U.S. Drug Enforcement Administration drug fact sheets, dea.gov.

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

PubChem CID
N/A — no single PubChem compound (mixture/class/plant/concept)
IUPAC name
N/A — no single PubChem compound (mixture/class/plant/concept)
Molecular formula
N/A — no single PubChem compound (mixture/class/plant/concept)
SMILES
N/A — no single PubChem compound (mixture/class/plant/concept)
InChIKey
N/A — no single PubChem compound (mixture/class/plant/concept)
Synonyms / aliases
tusi, tucibi, tusibi, pink cocaine

Composition

Composition
Ketamine detected in ~93% and MDMA in ~92% of samples; 2C-B in only ~4% (470 'tusi' samples, Spanish drug-checking 2020–2024)Abukahok, Fitzgerald & Palamar, Current Addiction Reports (2025) · retrieved 2026-06-18

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Mixture — depends on detected componentsDEA / eCFR 21 CFR 1308 · retrieved 2026-06-18
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
See synthesized prose in dossiers/pink-cocaine.md (our words, cited)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
See synthesized prose in dossiers/pink-cocaine.md (our words, cited)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index